Independent KLH Toxicity & Immunogenicity Tests Complete
News Dec 01, 2010
Dr. Herbert Chow, VP Product Development, said, "Use of Stellar KLH as a potent adjuvant for immune stimulation, must be accomplished without causing increased susceptibility to infections, autoimmune reactions or immune suppression. The assessment of immunogenicity and immunotoxicity are therefore important steps for demonstrating safety in preclinical studies. In two separate pre-clinical studies, we have confirmed that Stellar KLH products, both our IMG and SUBUNIT forms, possess potent immune stimulatory effects with no observed safety or immunotoxicity problems. The data demonstrate the superiority of Stellar KLH/IMG as a dynamic adjuvant, and will support the regulatory filings leading to testing it in human studies."
Almost 95% of people with early-diagnosed breast cancer will require surgery and it’s often the first line of treatment for people with brain tumors, for example. But despite improvements in surgical techniques over the past decade, the cancer often comes back after the procedure. Now, a team has developed a spray gel embedded with immune-boosting drugs that could help.READ MORE